Flutamide
Rex N. Brogden, Stephen P. Clissold · Drugs · 1989
Cited by 106 works. doi:10.2165/00003495-198938020-00003
Authors
References
- Leuprolide versus Diethylstilbestrol for Metastatic Prostate Cancer
- Incidence of cardiovascular disease and death in patients receiving diethylstilbestrol for carcinoma of the prostate
- A Biological Profile of a Nonsteroidal Antiandrogen, SCH 13521 (4'–Nitro–3'–Trifluoromethylisobutyranilide)1
- Complete androgen blockade for the treatment of prostate cancer.
- Criteria for Evaluating Patient Responses to Treatment Modalities for Prostatic Cancer
- Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone
- On the Mechanism of the Anti-androgenic Action ofFlutamide (α-α-α-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide)in the Rat
- Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues
- Experience with flutamide in patients with advanced prostatic cancer without prior endocrine therapy
- Comparison of the antiandrogenic/androgenic activities of flutamide, cyproterone acetate and megestrol acetate